Drosophila RET fusion cancer models have multiple transformation phenotypes
Similar to patients, NCOA4-RET presents with more severe phenotypes than CCDC6-RET
CCDC6-RET and NCOA4-RET activate distinct pathways and have different drug sensitivity
A drug treatment, sorafenib plus AZD1775 (MK-1775), was effective for NCOA4-RET animals